It’s Still Early Days. But Pfizer’s Stunning Vaccine Results Could Be a Real Game-Changer

It’s Still Early Days. But Pfizer’s Stunning Vaccine Results Could Be a Real Game-Changer

It’s Still Early Days. But Pfizer’s Stunning Vaccine Results Could Be a Real Game-Changer

By Jeffrey S. Flier at Quillette
With COVID-19 cases surging in the United States and many other countries, Monday’s announcement that ongoing vaccine tests had produced positive results comes as much-needed good news. In a placebo-controlled trial of 43,538 subjects, a vaccine developed by Pfizer, working with the German company BioNTech, was found to be “more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection.”
Pfizer officials added that they “will continue to collect further data as the trial continues to enroll for a final analysis planned when a total of 164 confirmed COVID-19 cases have accrued”; that the monitoring committee had “not reported any serious safety concerns”; and that “based on current projections, we expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.”
article date: 2020 11 11
posted: 2020-11-11 22:01:46
Tags:

Read the original post >

Related News